Botox Market, By Type (Botulinum Toxin Type-A and Botulinum Toxin Type-B), By End-use (Therapeutic Use and Aesthetic Use), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) – Trends, Analysis, and Forecast till 2030

Report Code: PMI99019 | Publish Date: July 2023 | No. of Pages: 168

Global Botox Market By Type Overview

Introduction:

Botox is a neurotoxic protein produced during reproduction process by the bacterium Clostridium botulinum and related species. Botox is a polypeptide which has a molecular weight of 150kD and is also one of the most poisonous natural proteins. Botox is very easy to produced, purified and refined due to its stable property. Botox has wide application in experimental research and clinical applications. Botox may be a protein made up of neurotoxin, which the bacterium botulinus produces. This is often an equivalent toxin that causes botulism. Botox may be a toxin, but when doctors use it correctly and in small doses, it can have benefits. It’s both cosmetic and medical uses. As a cosmetic treatment, Botox injections can reduce the looks of skin wrinkles. Also, the Food and Drug Administration (FDA) have approved it as a treatment for various health issues, including eyelid spasms, excessive sweating, some bladder disorders, and migraine. The Botox Market accounted for US$ 5.15 billion in 2020 and is estimated to be US$ 10.60 billion by 2030 and is anticipated to register a CAGR of 7.50%.

Global Botox Market By Type Dynamics

                                                                   

Surging demand for minimally invasive treatment

Escalating population aging between 25 years to 65 years to age, surging demand for minimally invasive treatment and escalating therapeutic utility of botulinum toxin are the major driving factors of the global botox market.

Heavy investment on R&D projects

In addition, heavy investment on R&D projects to develop the therapeutic use of botox is creating numerous opportunities in the global market across the globe. Botox is more financially viable for patients, patients may notice the results of botox immediately, botox injections are less invasive than other cosmetic procedures, and it is a versatile treatment. These benefits are expected to fuel the demand of the global market over the forecast period.

Side effects

However, side effects such as allergic reactions, rash, neck and back pain, difficulty in swallowing, shortness of breath and nausea is one of the major restraining factors of the global market across the globe. Moreover, high cost entailed in performing such expensive procedures, and poor reimbursement coverage for product is also hindering the market growth of the global market

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Botox Market By Type Segmentation

                                            

The global botox market is segmented based on type, end-use, and region.

On the basis of type, the global market is segmented into botulinum toxin type-A and botulinum toxin type-B. The botulinum toxin type-A segment held a prominent share of the global botulinum toxin market in 2018. Increase in prevalence of cervical dystonia, spasticity, glabellar lines, and crow’s foot and rise in the use of botulinum toxin type-A are key factors propelling the global market.  Based on end-use, the target market is bifurcated into therapeutic use and aesthetic use. The therapeutics end-use segment dominates the global market, owing to global rise in the cases of migraine and increase in the demand for non-surgical therapeutic procedure, which is noninvasive or minimally invasive in nature.

Regional Insights:

                                  

For detailed understanding of market dynamics, on the basis of region, the global botox market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is the largest supplier of botox, and dominates the global botox market, owing to the rise in awareness level regarding non-surgical esthetic and therapeutic procedures. The global market in North America is expected to maintain its dominant position over the forecast period. The global market in Europe is the second largest supplier of botox, and is expected to expand over the forecast period, due to increase in geriatric population. The global market in Asia Pacific is projected to expand over the forecast period, owing to the rise in adoption of non-surgical botulinum toxin procedures by the geriatric population and favorable government regulations.

                                         

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2029

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Type- Botulinum Toxin Type-A and Botulinum Toxin Type-B

By End-User- Therapeutic use and Aesthetic use

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Detailed Segmentation:

Global Botox Market, By Region:

      • North America
        • North America Global Botox Market, By Type
        • North America Global Botox Market, By End-User
        • North America Global Botox Market, By Country
          • Canada
          • Europe
        • Europe Global Botox Market, By Type
        • Europe Global Botox Market, By End-User
        • Europe Global Botox Market, By Country
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
        • Asia Pacific Global Botox Market, By Type
        • Asia Pacific Global Botox Market, By End-User
        • Asia Pacific Global Botox Market, By Country
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
        • Latin America Global Botox Market, By Type
        • Latin America Global Botox Market, By End-User
        • Latin America Global Botox Market, By Country
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
        • Middle East & Africa Global Botox Market, By Type
        • Middle East & Africa Global Botox Market, By End-User
        • Middle East & Africa Global Botox Market, By Country
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Botox Market By Type Key Players

                                                                                 

The key players operating in the global botox market includes Allergan, Inc., Ipsen Group, Merz Pharma GmbH & Co. KGaA, Medytox, Inc., US Worldmed, LLC, Metabiologics, Inc., Lanzhou Institute of Biological Products Co. Ltd., Revance Therapeutics, Inc., Allergan, Inc., Ipsen Group, and Merz Pharma GmbH & Co. Advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the Global Botox Market.

Global Botox Market By Type Company Profile

  • Allergan, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
  • Ipsen Group
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
  • Merz Pharma GmbH & Co. KGaA
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
  • Medytox, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
  • US Worldmed
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
  • Metabiologics, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
  • Lanzhou Institute of Biological Products Co. Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
  • Revance Therapeutics, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
  • Allergan, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
  • Ipsen Group
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

Global Botox Market By Type Table of Contents

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By End-User
      • Market Snippet, By Region
    • Opportunity Map Analysis
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Market Trends
    • Product Launch
    • Impact Analysis
    • PEST Analysis
    • Porter’s Analysis
  4. Global Botox Market, By Type, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Botulinum Toxin Type-A
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Botulinum Toxin Type-B
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  5. Global Botox Market, By End-User, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Therapeutic Use
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Aesthetic Use
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  6. Global Botox Market, By Region, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Allergan, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Ipsen Pharma SA
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Merz Pharma GmbH & Co. KGaA, Medytox, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • US Worldmed, LLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Metabiologics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Lanzhou Institute of Biological Products Co. Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Revance Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Allergan, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Ipsen Group
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Medytox Korea Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
    • Analyst Views
  8. Section
    • Research Methodology
    • About Us
    • Contact

FAQs

The global botox market is segmented based on type, end-use, and region

Escalating population aging between 25 years to 65 years to age, surging demand for minimally invasive treatment and escalating therapeutic utility of botulinum toxin are the major driving factors of the global botox market.

North America is the largest supplier of botox, and dominates the global botox market, owing to the rise in awareness level regarding non-surgical esthetic and therapeutic procedures.

The prominent key operating in the global market have adopted key strategies such as collaborations, mergers, acquisitions, and partnerships to strengthen their market outreach and sustain the stiff competition in the market. For instance, in June 2019, US drugmaker AbbVie has agreed to buy Allergan, the Irish-domiciled maker of Botox, in a US$63 bn deal that is the sector’s latest blockbuster transaction driven by the need to replenish drug pipelines.